IL-31 targeting has proven to be a safe and convenient method to treat itching, and it also has shown some potential in treating oncological diseases and a plethora of inflammatory conditions that could lead to organ failures, such as hepatitis and sepsis. This evidence concerns the gene IL31 and Hepatitis.